DIALYSIS · CCN 332761

DaVita Melrose Dialysis

BRONX, NY 10455

DialysisProfitDaVita
$6.1M
TOTAL REVENUE
2.2%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.1M
Total costs
$6.0M
Operating income (rev − costs)
$135K
Operating margin
2.2%
Total charges
$6.1M
Total treatments
16,418
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.6438—
Fistula Rate
DFC_FISTULA_RATE
71.7118—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.5789—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
149.686—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
12118—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
12.4349—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
20.3102—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
30.487—
Standardized ED Visits Ratio
DFC_SEDR
1.0222—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
26.518—